newsfilter
← Latest News
PR Newswire·

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines,...